Literature / Brochures

How to Manage Anterior Epistaxis Using Bioresorbable Nasal Packing

All-in-One Solution for Hemostasis, Healing, and Comfort in Nasal Surgery

Company Logo

Released By Maxigen Biotech Inc.

What are the two types of nasal packing?
Nasal packing plays a pivotal role in managing epistaxis and supporting postoperative healing following ENT procedures. Clinically, nasal packing materials are classified into two primary categories based on the location of bleeding:

  • Anterior nasal packing, used to treat bleeding in the front of the nasal cavity, accounts for over 90% of epistaxis cases.
  • Posterior nasal packing, indicated for bleeding from deeper vascular sources, is typically used in more severe or refractory situations.

Understanding Anterior Epistaxis and the Role of Nasal Packing
Anterior epistaxis, typically originating from Kiesselbach’s plexus in the anterior nasal septum, accounts for the majority of nosebleed cases encountered in emergency departments and ENT clinics. When first-line measures such as direct compression or topical vasoconstrictors are insufficient, nasal packing is often required to achieve hemostasis and support mucosal recovery.

Nasal packing materials generally fall into two categories: non-absorbable and bioabsorbable. While non-absorbable options like gauze or synthetic sponges are common, they often lead to mucosal trauma, patient discomfort, and require painful removal. In contrast, bioabsorbable nasal packing represents a more advanced and patient-friendly alternative, particularly suited for outpatient and postoperative care. In certain cases, bioabsorbable packing can also be used in combination with posterior techniques when deeper or bilateral support is necessary.

As otolaryngology practices continue to prioritize efficient, patient-centered treatment, NasoAid® nasal dressing stands out as a next-generation solution. Designed for anterior epistaxis management, it combines bioabsorbability, effective hemostatic action, and ease of use to enhance clinical outcomes and improve the overall patient experience. Its unique composition of 70% natural collagen and 30% carboxymethyl cellulose (CMC) works synergistically to promote rapid blood clotting and support mucosal healing, offering both superior hemostasis and accelerated tissue recovery.

Recommended Technique for Anterior Epistaxis Using NasoAid®

  1. Site preparation: Clear clots and apply vasoconstrictor drops to minimize active bleeding.
  2. Customize the packing: Trim NasoAid® to fit the anatomy and moisten with sterile saline if desired.
  3. Insert: Use sterile forceps to gently place the material into the anterior nasal cavity.
  4. Allow absorption: Leave the dressing in place. It will gradually dissolve over time without the need for removal. If clinically indicated, it can also be gently suctioned out by the physician with minimal discomfort.
  5. Monitor patient: Advise on follow-up only if symptoms persist. Most patients resume normal activities with minimal discomfort.

Market Trends and Clinical Relevance
According to a 2023 report by Research and Markets, the global nasal packing device market is projected to reach USD 248.56 million by 2029. This growth is attributed to a rising prevalence of chronic sinusitis and increased demand for absorbable, less painful solutions. NasoAid® nasal dressing is ideally positioned in this landscape, offering practical benefits to both clinicians and patients.

Ready to upgrade your epistaxis management strategy?
Contact us today to learn more about NasoAid® or to request a sample for clinical evaluation.

📥 Request more information from Maxigen Biotech Inc.

Request more information from Maxigen Biotech Inc.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters